- Presentations
- 3
- Markets
- 1
Simtriyo is a brand of Centanafadine marketed by Otsuka America Pharmaceutical, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Centanafadine
- Brand owner
- Otsuka America Pharmaceutical
- Registered in
- United States
- Strengths and forms
- 140 mg extended-release capsule, 210 mg extended-release capsule, 280 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Simtriyo 140 mg extended-release capsuleOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Simtriyo 210 mg extended-release capsuleOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Simtriyo 280 mg extended-release capsuleOral | Otsuka America Pharmaceutical | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Simtriyo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.